Physician profile
Roy Kohler
NPI 1215933676
$2,364.73
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $53.31 · 2021: $262 · 2022: $1,521 · 2023: $280 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,699.28 | 2021-2024 | Inspire |
| Jazz Pharmaceuticals INC. | $156.36 | 2022 | |
| Harmony Biosciences LLC | $120.94 | 2020-2023 | Wakix |
| Philips North America LLC | $118.99 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $75.62 | 2021-2023 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.31 | 2021 | |
| Resmed Corp | $38.84 | 2019 | |
| Glaxosmithkline, LLC. | $32.77 | 2023 | Arexvy, Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $20.84 | 2021 | |
| United Therapeutics Corporation | $18.99 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.43 | 2023 | Airsupra |
| Grifols USA, LLC | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Kohler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.